Cem Akın
Immunology and Microbiology · University of Michigan
Publications
24
Citations
35
Est. group size
—
Recurring co-author estimate
Active years
25
Publishing since 2001
Typically publishes in teams of ~11 · 22% small-team papers (≤3 authors) · across 8 venues
- An analysis of clonal dynamics in patients with indolent systemic mastocytosis treated with avapritinib in the pioneer study
Blood · 2025
- Diagnostic evolution in systemic mastocytosis: Clinical impact of who 2022 criteria on smoldering systemic mastocytosis identification in pioneer
Blood · 2025
- Avapritinib achieves deep and durable symptom control with a well-tolerated safety profile in ism: Long-term outcomes from pioneer
Blood · 2025
- POSTER: MPN-577 Favorable Benefit-Risk Profile of Avapritinib in Indolent Systemic Mastocytosis Is Maintained After 3 Years of Therapy: Longer-Term Analysis of the PIONEER Study
Clinical Lymphoma Myeloma & Leukemia · 2025
- POSTER: MPN-1082 Identification of Clonal Mast Cell Disease in Patients With Anaphylaxis or Evidence of Systemic Mast Cell Activation: A Post Hoc Analysis From PROSPECTOR
Clinical Lymphoma Myeloma & Leukemia · 2025
- MPN-1082: Identification of Clonal Mast Cell Disease in Patients With Anaphylaxis or Evidence of Systemic Mast Cell Activation: A Post Hoc Analysis From PROSPECTOR
Clinical Lymphoma Myeloma & Leukemia · 2025
- MPN-577: Favorable Benefit-Risk Profile of Avapritinib in Indolent Systemic Mastocytosis Is Maintained After 3 Years of Therapy: Longer-Term Analysis of the PIONEER Study
Clinical Lymphoma Myeloma & Leukemia · 2025
- POSTER: MPN-573 Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis Patients and Establishing Content Validity
Clinical Lymphoma Myeloma & Leukemia · 2025
- Avapritinib Impacts the Plasma Inflammatory Proteome in Patients With Indolent Systemic Mastocytosis (ISM)
Journal of Allergy and Clinical Immunology · 2025
- Long-term Quality of Life and Safety in Patients with Indolent Systemic Mastocytosis Treated with Avapritinib in the PIONEER Study
Journal of Allergy and Clinical Immunology · 2025
- Identification of Clonal Mast Cell Disease in Patients With Anaphylaxis or Evidence of Systemic Mast Cell Activation: A Post Hoc Analysis From PROSPECTOR
Journal of Allergy and Clinical Immunology · 2025
- Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium
Journal of Allergy and Clinical Immunology · 2025
- TÜRKİYE’DE NEOLİBERAL BELEDİYECİLİK: BÜYÜKŞEHİR BELEDİYELERİ ÜZERİNE ANALİTİK BÜTÇE SINIFLANDIRMASI TEMELİNDE ÇÖZÜMLEME
Memleket Siyaset Yönetim · 2024
- Türkiye’de Serbest Liman Kentlerindeki Kamu Yatırımlarının ve Mali Teşviklerin Yerel Düzeydeki Ekonomik Büyüme Dinamikleri Üzerine Etkileri
Sosyoekonomi · 2024
- Yerel Yönetimler ve Yönetişim: Türkiye’de Kategorileri İtibariyle Belediyelerin Bütçe Giderlerinin TOPSIS Yöntemi ile Analizi (2006-2019)
Sosyoekonomi · 2023
- Clinical Lymphoma Myeloma & Leukemia×5
- Journal of Allergy and Clinical Immunology×4
- Blood×3
- Sosyoekonomi×2
- Leukemia & lymphoma/Leukemia and lymphoma×1
- Varsha Ganesan
Immunology and Microbiology · University of Michigan
- Cem Akin
Immunology and Microbiology · University of Michigan
- HM Kim
Immunology and Microbiology · University of Michigan
- Dilawar Khokhar
Medicine · University of Michigan
- Masako Toda
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile